Combination Treatment of Deep Sea Water and Fucoidan Attenuates High Glucose-Induced Insulin-Resistance in HepG2 Hepatocytes
Open Access
- 2 February 2018
- journal article
- research article
- Published by MDPI AG in Marine Drugs
- Vol. 16 (2) , 48
Abstract
Insulin resistance (IR) plays a central role in the development of several metabolic diseases, which leads to increased morbidity and mortality rates, in addition to soaring health-care costs. Deep sea water (DSW) and fucoidans (FPS) have drawn much attention in recent years because of their potential medical and pharmaceutical applications. This study investigated the effects and mechanisms of combination treatment of DSW and FPS in improving IR in HepG2 hepatocytes induced by a high glucose concentration. The results elucidated that co-treatment with DSW and FPS could synergistically repress hepatic glucose production and increase the glycogen level in IR-HepG2 cells. In addition, they stimulated the phosphorylation levels of the components of the insulin signaling pathway, including tyrosine phosphorylation of IRS-1, and serine phosphorylation of Akt and GSK-3β. Furthermore, they increased the phosphorylation of AMPK and ACC, which in turn decreased the intracellular triglyceride level. Taken together, these results suggested that co-treatment with DSW and FPS had a greater improving effect than DSW or FPS alone on IR. They might attenuate IR by targeting Akt/GSK-3β and AMPK pathways. These results may have some implications in the treatment of metabolic diseases.Keywords
Funding Information
- A Project of Shandong Province Higher Educational Science and Technology Program (J16LM07)
- Shandong Provincial Natural Science Foundation, China (ZR2015HM080)
- The Project of Research and development of Shandong Province (2017GSF19105)
This publication has 46 references indexed in Scilit:
- The role of hepatic lipids in hepatic insulin resistance and type 2 diabetesNature, 2014
- Modulation of Lipid Metabolism by Deep-Sea Water in Cultured Human Liver (HepG2) CellsMarine Biotechnology, 2013
- Deep Sea Water Modulates Blood Pressure and Exhibits Hypolipidemic Effects via the AMPK-ACC Pathway: An in Vivo StudyMarine Drugs, 2013
- AMPK: A Target for Drugs and Natural Products With Effects on Both Diabetes and CancerDiabetes, 2013
- Recent discovery of plant-derived anti-diabetic natural productsNatural Product Reports, 2012
- Glycaemic control in type 2 diabetes: Targets and new therapiesPharmacology & Therapeutics, 2010
- Epigallocatechin gallate (EGCG) attenuates high glucose‐induced insulin signaling blockade in human hepG2 hepatoma cellsMolecular Nutrition & Food Research, 2008
- New Insights into the Pathogenesis of Insulin Resistance in Humans Using Magnetic Resonance SpectroscopyObesity, 2006
- 5′-AMP-activated Protein Kinase Phosphorylates IRS-1 on Ser-789 in Mouse C2C12 Myotubes in Response to 5-Aminoimidazole-4-carboxamide RibosideJournal of Biological Chemistry, 2001
- Selective Attenuation of Metabolic Branch of Insulin Receptor Down-signaling by High Glucose in a Hepatoma Cell Line, HepG2 CellsJournal of Biological Chemistry, 2000